
Introducing The Journal: Trillion Dollar Shot
Science Vs
The Launch and Marketing of Ozempic
This chapter details the launch of the drug Ozempic in the US in 2018, focusing on Novo Nordisk's marketing strategies, including a catchy jingle to increase awareness. It also explores the off-label usage of Ozempic for weight loss, the challenges associated with this practice, and the caution expressed by industry leaders about promoting the obesity effect of GLP1 drugs.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.